Integra LifeSciences
IART
168 hedge funds and large institutions have $1.7B invested in Integra LifeSciences in 2015 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 75 increasing their positions, 50 reducing their positions, and 10 closing their positions.
562% more call options, than puts
Call options by funds: $980K | Put options by funds: $148K
120% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 10
50% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 50
6% more funds holding
Funds holding: 158 → 168 (+10)
15% less capital invested
Capital invested by funds: $2B → $1.7B (-$309M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.2M |
| 2 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$11M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$10.7M |
| 4 |
HM
HealthCor Management
New York
|
+$10.1M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$6.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Americafirst Capital Management
Roseville,
California
|
-$575M |
| 2 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$12.8M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$9.95M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$6.07M |
| 5 |
Goldman Sachs
New York
|
-$3.98M |
IART Hedge Fund Activity: Q1 2015 in Review
168 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2015, worth a combined $1.7B — down 15% from $2B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new IART positions and 10 closed out — a net gain of 12 holders — while 75 added to existing stakes and 50 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $32.2M. The largest seller was Americafirst Capital Management, exiting entirely with an estimated $575M sold.
- 168 institutional investors held Integra LifeSciences (IART) as of Q1 2015, up from 158 in Q4 2014.
- Funds reported $1.7B of Integra LifeSciences stock for Q1 2015, down 15% quarter-over-quarter.
- 22 funds opened new Integra LifeSciences positions in Q1 2015 and 10 closed out, a net change of +12 holders.
- The largest Integra LifeSciences buyer in Q1 2015 was Fidelity Investments, an estimated $32.2M added.
- The largest Integra LifeSciences seller in Q1 2015 was Americafirst Capital Management, an estimated $575M sold.
Based on aggregated 13F filings for Q1 2015.